Retatrutide, by Soma Chems , represents a promising development in weight management . This dual-action compound combines GLP-1 receptor agonist activity with GIP pathway activation , indicating substantial efficacy in clinical data for body improvement. Experts believe the drug is expected to provide a new option for individuals facing excess weig